期刊
OPEN FORUM INFECTIOUS DISEASES
卷 9, 期 1, 页码 -出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofab643
关键词
antibiotic resistance; carbapenemase; carbapenem-resistant Enterobacterales; ertapenem
资金
- EIP Surveillance of the Multi-site Gram Negative Surveillance Initiative
- Centers for Disease Control and Prevention's Emerging Infections Program [U50CK000485]
Ertapenem-mono-resistant CRE have distinct clinical and microbiologic characteristics from other CRE, and they rarely have carbapenemase genes.
Background. Carbapenem-resistant Enterobacterales (CRE) are highly antibiotic-resistant bacteria. Whether CRE resistant only to ertapenem among carbapenems (ertapenem mono-resistant) represent a unique CRE, subset with regards to risk factors, carbapenemase genes, and outcomes is unknown. Methods. We analyzed surveillance data from 9 CDC Emerging Infections Program (EIP) sites. A case was the first isolation of a carbapenem-resistant Enterobacter cloacae complex, Escherichia coil, Klebsiella aerogenes, K. oxytoca, K. pneumoniae, or K. variicola from a normally sterile site or urine in an EIP catchment area resident in 2016-2017. We compared risk factors, carbapenemase genes, antibiotic susceptibility, and mortality of ertapenem mono-resistant cases to other CRE cases (resistant to >= 1 carbapenem other than ertapenem) and analyzed risk factors for mortality. Results. Of 2009 cases, 1249 (62.2%) were ertapenem-mono-resistant and 760 (37.8%) were other CRE. Ertapenem-monoresistant CRE, cases were more frequently >= 80 years old (29.1% vs 19.5%; P < .0001) and female (67.9% vs 59.0%; P < .0001). Ertapenem-mono-resistant isolates were more likely to be Enterobacter cloacae complex (48.4% vs 15.4%; P < .0001) but less likely to be isolated from a normally sterile site (7.1% vs 11.7%; P < .01) or to have a carbapenemase gene (2.4% vs 47.4%; P < .0001). Ertapenem-mono-resistance was not associated with 90-day mortality in logistic regression models. Carbapenemase-positive isolates were associated with mortality (odds ratio, 1.93; 95% CI, 1.30-2.86). Conclusions. Ertapenem-mono-resistant CRE rarely have carbapenemase genes and have distinct clinical and microbiologic characteristics from other CRE. These findings may inform antibiotic choice and infection prevention practices, particularly when carbapenemase testing is not available.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据